Zivo Bioscience- Warrants (29/04/2026) Receivables

Zivo Bioscience- Warrants (29/04/2026) (ZIVOW) currently reports a receivables of $0 as of June 2026. That compares with $34K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Zivo Bioscience- Warrants (29/04/2026)'s receivables history and peer comparisons.

Zivo Bioscience- Warrants (29/04/2026)'s receivables decreased from $34K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zivo Bioscience- Warrants (29/04/2026) reported $0 in receivables as of June 2026. That compares with $34K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zivo Bioscience- Warrants (29/04/2026), and consider following ZIVOW for alerts when major investors trade the stock.

Zivo Bioscience- Warrants (29/04/2026) is classified in the Consumer Discretionary sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing ZIVOW with unrelated industries.